Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

Bibliographic Details
Main Authors: Cummins, K D, Jane, S M, Nikovic, S, Bazargan, A, Filshie, R, Sutrave, G, Hertzberg, M, Scott, A, Lane, S, Yannakou, C K, Ritchie, D, D'Rozario, J, Black, J, Bavishi, K, Wei, A
Format: Online
Language:English
Published: Nature Publishing Group 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219469/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219469/

Similar Items